An Open-label, Randomized, Controlled, 4-week Comparative Clinical Trial of Barnidipine Hydrochloride, a Calcium-channel Blocker, and Benazepril, an Angiotensin-converting Enzyme Inhibitor, in Chinese Patients with Renal Parenchymal Hypertension

Author： Chen X   Zheng F   Chen P   Tang L   Wei R   Yu Y   Su Y   Kikkawa T   Yamamoto M  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.34, Iss.2, 2006-03, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension

By Redón Josep   Trenkwalder Peter RA   Barrios Vivencio  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 155-164

Informa Healthcare

Access to resources Recommend Favorite

A 24-week Dose-titration Study of the Angiotensin-converting Enzyme Inhibitor Imidapril in the Treatment of Mild-to-moderate Essential Hypertension in the Elderly

By Dews I   VandenBurg M  

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 100-107

Field House Publishing

Access to resources Recommend Favorite

Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial

By Rizkallah Élie   Stip Emmanuel   Zhornitsky Simon   Pampoulova Tania   Gendron Alain   Rompré Pierre-Paul   Chiasson Jean-Pierre   Potvin Stéphane  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2947-2951

Informa Healthcare

Access to resources Recommend Favorite

Manidipine for Hypertension not Controlled by Dual Therapy in Patients with Diabetes Mellitus: A Non-Comparative, Open-Label Study

By Martell-Claros Nieves  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 427-434

Adis International

Access to resources Recommend Favorite

Antiproteinuric Effect of Angiotensin-converting Enzyme Inhibitors and an Angiotensin II Receptor Blocker in Patients with Lupus Nephritis

By Kitamura N   Matsukawa Y   Takei M   Sawada S  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 892-898

Field House Publishing

Access to resources Recommend Favorite